Mark S. Berger, M.D. was appointed as Chief Medical Officer at Genprex, Inc..
“Effective as of September 27, 2021, the Board of Directors (the "Board") of Genprex, Inc. ("Genprex") appointed Mark S. Berger, M.D. as Chief Medical Officer of Genprex.”
Source-grounded facts extracted from Genprex, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Mark S. Berger, M.D. was appointed as Chief Medical Officer at Genprex, Inc..
“Effective as of September 27, 2021, the Board of Directors (the "Board") of Genprex, Inc. ("Genprex") appointed Mark S. Berger, M.D. as Chief Medical Officer of Genprex.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.